Legal Landscape and Broader Context
The complaint argues BAT either knew or recklessly disregarded that its alleged illicit partnership was financing missile and rocket attacks carried out by the IRGC and Hezbollah. It claims the company persisted in the venture for at least a decade despite repeated warnings and widespread reporting about North Korea’s support for terrorism.
The suit comes against a complex legal backdrop. In 2023, the U.S. Supreme Court unanimously ruled that victims of a 2017 Islamic State attack could not recover damages from Facebook, Twitter and Google, finding that inaction alone was insufficient without proof the companies “consciously and culpably” assisted the terrorist act.
Just last week, however, a federal appeals court in Washington revived a separate lawsuit accusing pharmaceutical companies of funding terrorism in Iraq by allegedly paying bribes to a Hezbollah-controlled militia to secure health ministry contracts. The companies in that case deny wrongdoing.
In the case against BAT, plaintiffs argue the evidence goes beyond passive conduct. They cite public and private reports, corporate filings and internal monitoring of U.S. government and media statements about terrorist financing risks.
“Its in-house personnel closely monitored U.S. government and media reports,” the complaint states, asserting BAT was acutely aware of the risks posed by the illicit cigarette trade and North Korea’s alleged support for terrorism.
Now, as the British American Tobacco North Korea terrorism lawsuit unfolds, the courtroom may become the next battleground in a long-running conflict over accountability, sanctions and the cost of global commerce conducted in the shadows.
